Decoding Analytical Data: How WBCIL Uses UV and IR Spectroscopy to Validate Ferrous Ascorbate
Introduction
Think of ferrous ascorbate characterisation as unravelling a hidden tapestry, where each thread reveals the compound’s strength against anaemia’s shadow. At West Bengal Chemical Industries Ltd (WBCIL), characterisation is not ‘just another job’. It is a commitment to providing a high-quality, ‘true to life’ version of a pharmaceutical-grade ferrous ascorbate Active Pharmaceutical Ingredient (API).
Millions of people suffer from variations of iron deficiency anaemia [1]. Our product, ferrous ascorbate, the necessary (and often overlooked) companion for those who are iron-deficient, enhances the characterisation of iron, where most of the other products do not have consistency with respect to bioavailability [2]. So why the emphasis on stability studies? [3] Like a bricharacterisatione storms, ferrous ascorbate characterisation demands analytical verification to spot cracks—hygroscopicity, oxidation pathways—that could erode efficacy [4].
WBCIL dives deep into ferrous ascorbate characterisation and IR spectroscopy, using them as lanterns in the lab’s twilight [5]. By illuminating the structure and purity of ferrous ascorbate, these tools verify that the batches’ characteristics are consistent. In this way, the combination of science and care through the use of spectral information offers confidence in the quality and reliability of each batch of ferrous ascorbate, with each spectrum saying “trust me.” [6]
Who would have thought that something as simple as a scan could potentially save lives? [7] Join us as we use molecular whispers to guide our characterisation of ferrous ascorbate [8]. This process also demonstrates why WBCIL has superior quality to all others [9].
Takeaways:
- Spectroscopy Confirms Identity and Purity: WBCIL uses UV Spectroscopy to precisely quantify the ferrous ions and IR Spectroscopy to confirm the molecular structure using characteristic functional group peaks . This dual-spectroscopic approach ensures the correct identity and high purity of the Ferrous Ascorbate API batch.
- Stability is Managed Against Oxidation and Moisture: The compound is highly vulnerable to degradation via oxidation and hygroscopicity (moisture absorption leading to swelling). WBCIL minimises oxidation using nitrogen purging during manufacturing and controls hygroscopicity via granulation and specific excipients, which is then validated using stringent forced degradation tests.
- Analytical Methods are Rigorously Validated: All UV/IR protocols strictly adhere to ICH Q2(R2) guidelines, ensuring reliability. Key parameters like high linearity , repeatability, and robustness are continually verified to eliminate fraud and ensure the consistently high pharmaceutical-grade quality of the ferrous ascorbate.
What is Ferrous Ascorbate?
Characterising ferrous ascorbate shows that it is the result of combining iron in the form of Fe²⁺ with ascorbic acid—two substances that work together to provide nutrition to plants and give them strength for growth. Ferrous ascorbate is a form of L-(+)-Ascorbic Acid Iron (II) Salt; it is violet and odourless, and occurs as a fine powder made from ferrous sulphate [10]. It has no flavour, which means it can be easily added to the diet [11].
In a pharmaceutical context, ferrous ascorbate characterisation spotlights its role in the treatment of iron-deficiency anaemia—ascorbate reduces ferric iron, enabling duodenal uptake, where gastric HCl paves the way [12].
Common applications? The assignment of ferrous ascorbate shows its superior bioavailability compared to other ferric forms (ferrous), thus avoiding GI problems such as nausea [13]; however, it faces the challenge of its hygroscopic nature, as once hygroscopic materials absorb enough moisture, they become jammed [14].
The drying-out effect, exacerbated during solid-state characterisation, increases the risk of blockages in powder or tablet form [8]. Ferrous ascorbate characterisation using analytical methods reveals excipient-related matrix effects, underscoring the need for an innovative formulation [15].
What UV λmax indicates ferrous ions?
That 265 nm glow in water is a ferrous ascorbate characterisation beacon [16]. Ferrous ascorbate is characteristically forging developed by WBCIL, allowing for changes and adaptations in bulk density (0.11g/mL), Hausner Ratio (1.27—acceptable ratio) using Carr’s Compressibility Scale (16-21% or passable) [5]. Granulations reduce the hygroscopic characteristics of the ferrous ascorbate; and the binders used to prevent swelling due to absorption of moisture [6]. When Characterising ferrous ascorbate “dry, cool” refers to the minimal degradation (0.54%acidity) [17].
How can oxidation of the ferrous ascorbate be eliminated? Using nitrogen during processing [18].
Stability Challenges of Ferrous Ascorbate
Ferrous Ascorbate characterisation has a high candidate risk due to instability; a small amount of moisture can disrupt the equilibrium potential for degradation [8]. Ferrous ascorbate is present in multiple forms: Oxidation Pathways’ Fe[II] will be converted into Fe[III] via hydrolysis, consuming water to solvate its bonds and become hydrolysed [4]. This will allow the oxidation of ferrous ascorbate [10]. Hygroscopicity reigns as the sly intruder, characterisation to inflate structures, per swelling indices climbing to 2.06 over 21 days in our studies [14].
Moisture sensitivity heightens oxidation pathways, especially in humid tropics, where ferrous ascorbate characterisation flags shifts early [14]. Characterisation, 33.82% under UV, thermolysis 29.09% at 120°C—harsh truths from forced tests [20].
Stable formulations?
Crucial, lest shelf-life prediction crumbles, impurities bloom like characterisationscorbate characterisation stresses repeatability & robustness, which are addressed to counter these [19].
How to prevent oxidation in ferrous ascorbate?
Inert gases and antioxidants, characterisation of ferrous ascorbate [18]. Analytical methods for ferrous ascorbate use baseline correction to provide characterisation effects from excipients that muddy assays, but ferrous ascorbate characterisation clarifies, ensuring validation holds [16]. We are committed to enhancing stable territories through ferrous ascorbate characterisation, which allows us to develop ways to respond to our enemies [5].
Techniques of Analysis that Verify Honour
Ferrous Ascorbate Characterisation uses Spectroscopy as a Method of Investigating Bonds by Using Light as a Device. What Role Does UV Spectroscopy Play in QC in the Pharmaceuticals? It captures electronic leaps—UV hits ferrous ascorbate at 265 nm (water) or 243 nm (HCl), with absorbance ~0.25, signalling ions via Beer’s Law, perfect for assays and impurity hunts [16].
IR spectroscopy vibrates like a symphony [5]. Characterisation of the Spectrum of Ferrous Ascorbate hums OH at 3420 cm⁻¹, C=O at 1740 cm⁻¹, C-O at 1080 cm⁻¹. Which IR peaks confirm ferrous ascorbate? These via peak assignment, etching identity. Ferrous ascorbate characterisation leverages them for non-invasive purity checks, spotting degradation sans destruction.
Complementary?
HPLC on Zorbax SB-C8 (264 nm) separates peaks, aiding a stability-indicating method for ferrous ascorbate. Limit of detection dips to nM levels, baseline correction, and noise reduction. How to validate UV/IR per ICH Q2(R2)? Linearity (R²>0.999), specificity—characterisation of ferrous ascorbate from degradation products using UV via λmax drops or rogue bands at 300 nm.
Identifying functional groups in the Ferrous Ascorbate IR spectrum nails the structure; solid-state characterisation of ferrous ascorbate with polymorphs. Analytical methods of ferrous ascorbate blend these, quelling matrix effects with blanks. Spectroscopy’s duet—UV’s quick pulse, IR’s resounding echo—anchors ferrous ascorbate characterisation in truth.
WBCIL’s Analytical Methodology
In Characterisation of WBCIL’s Samples of ferrous ascorbate, the following Technical Specifications have been Adhered to for Accuracy & Precision: All the sample batches (FAS13782407B) dissolve rapidly in either distilled water or 0.1 N HCl, in a UV/Visible Double-Beam Spectrophotometer, scanned from 200 – 400nm at a 1nm slit width, and 200nm/min scan speed (Calibration Curves: the range between 5 – 50µg/ml, R2 = 0.999+ means Limit of Detection for Signal to Noise Ratio = 0.5µg/ml).
For IR, KBr pellets (1% load) are pressed at 10 tons; FTIR (Nicolet iS50) scans 4000-400 cm⁻¹ at 4 cm⁻¹ resolution, 32 scans—vacuum-dried to avoid hygroscocharacterisedation per ICH Q2(R2): repeatability sixfold (<2% RSD), robustness via pH tweaks ±0.1, wavelength ±2 nm; ANOVA p<0.05 on triplicates. Protocols developed by the authors describe the methods used to characterise ferrous ascorbate from a thermally pre-treated source (stress-temperature) for use in UV and IR Spectroscopy. The FTIR Spectral Analysis of ferrous ascorbate includes detailed information regarding each of the characteristic peaks; the UV assay data provides data regarding the post-degradation purity of ferrous ascorbate.
Models to predict the minimum life of ferrous ascorbate can be developed from thermal stability data using the Arrhenius equation [19]. The authors provide methods for the analysis of iron supplements, including blanks and excipients, to minimise the impact of matrix effects. Repeatability and robustness, or daily calibration, are required for the continued availability of pharmaceutical-grade ferrous ascorbate active pharmaceutical ingredient (API) [16].
Interpretation of UV and IR Spectra Spoxidisede to be analysed from the viewpoint of all spectra that we have taken, and what indicators will there be for determining whether Fe (iron) has been oxidised from its reduced state and if it will become oxidised again? [12] The differences between the spectral signatures of ferric and ferrous indicate that at this point, there is no presence of biogenic or chemical impurities; therefore, the oxidation routes identified through the spectra will be reliable in determining these differences. Methods used to isolate Fe (iron) from the remaining portions of ascorbic acid by using UV spectra will successfully separate the two components. The strong point of FTIR spectroscopy for this compound is the wide ranges of absorption bands due to the individual functional groups present in the compound [5].
FTIR provides significant evidence for the standardisation of Ferrous Ascorbate and has a strong signal for identifying functional groups associated with this compound, thus establishing any potential for future degradation of this compound. Transfer standardisation methods will lead to the establishment of shelf-life predictions based on changes in the intensity of the C=O peak associated with a reduction of 29%. Through the establishment of the unique functional groups associated with Ferrous Ascorbate based on the results of FTIR Spectroscopy, we have determined that Ferrous Ascorbate has an overall purity of more than 98%. Therefore, UV Spectroscopy can be used to accurately and precisely quantify the Ferrous characterisation. Based on the initial analysis of the samples, we can ascertain that these analyses can help eliminate fraud and misrepresentations.
Manufacturing and Stability Optimisation Ferrous ascorbate characterisation guides WBCIL’s forge: flow tweaks yield bulk density 0.11 g/mL, Hausner 1.27 (passable), compressibility 16-21% per Carr’s scale. Granules tame hygroscopicity; excipients bind against swelling. Characterisation: low degradation (0.54% acid) shapes dry, cool lines.
How to prevent oxidation in ferrous ascorbate?
Nitrogen flushes, coats [18]. Formulation buffers pH for repeatable characterisations. Solid state characterisation of ferrous ascorbate vets polymorphs, dialling compression for >5 kg hardness.
Packaging? Blisters with desiccants shield moisture sensitivity [17]. Ferrous ascorbate characterisation loops yield shelf-life prediction characterisation refining from granulation to finish—pharma-grade ferrous ascorbate API emerges battle-ready.
Forced Degradation and Packaging Considerations
Forced degradation in ferrous ascorbate characterisation simulates sieges: acid/base/neutral ~0.5-2% loss, oxidation 0.08%, but thermolysis 29.09%, photolysis 33.82%—HPLC screams 99% drops. A stability-indicating method for ferrous ascorbate via UV/IR spectroscopy unmasks products.
What is the characterisation of ascorbate stability? Alu-Alu blisters, silica gels barricade humidity, bolstering shelf-life prediction. optimisations yield, assays hold firm.
Conclusion
Ferrous ascorbate characterisation via UV/IR at WBCIL transmutes raw data into trusted pharma-grade ferrous ascorbate characterisation, firming purity, optimisations fending off decay. Spectroscopy’s gaze ensures stability, spotlighting WBCIL’s rigour in the fight against anaemia. What’s your take on ferrous ascorbate’s role in characterisation?
1. Al-Hajaj, N., Alharbi, A., Alharbi, F., Alharbi, S., & Alharbi, M. (2024). Comparative Efficacy of Ferrous, Ferric and Liposomal Iron Preparations for Prophylaxis in Infants. Cureus, 16(4), e58691. https://pubmed.ncbi.nlm.nih.gov/38655891/.
2. Moretti, D., Zimmermann, M. B., Wegmüller, R., & Hulmann, M. (2024). Efficacy and Safety of Oral Supplementation with Liposomal Iron in Non-Dialysis Chronic Kidney Disease Patients with Iron Deficiency. Nutrients, 16(9), 1255. https://pmc.ncbi.nlm.nih.gov/articles/PMC11085822/.
3. International Council for Harmonisation (ICH). (2003). ICH Guideline Q1A(R2): Stability Testing of New Drug Substances and Products. Geneva: ICH. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf.
4. Gupta, A., Singh, R., & Sharma, S. (2021). Hygroscopic properties of pharmaceutical excipients: a review. Asian Journal of Pharmaceutical and Clinical Research, 14(7), 5-11. https://innovareacademics.in/journals/index.php/ajpcr/article/view/42567.
5. WBCIL Journal on Ferrous Ascorbate: Banerjee, P. G., Paul, A., Chakraborty, A., Porel, A., & Mallick, P. (2025). Stability, characterization, and manufacturing optimization of ferrous Ascorbate: A Comprehensive Study by West Bengal Chemical Industries Ltd., Kolkata, India. International Journal of Pharmaceutical Research and Development, 7(1a), 32-37. https://doi.org/10.33545/26646862.2025.v7.i1a.91 (Full PDF: https://www.wbcil.com/wp-content/uploads/2025/02/Stability-characterization-and-manufacturing-.pdf).
6. British Pharmacopoeia Commission. (2023). British Pharmacopoeia 2023. London: TSO (The Stationery Office). https://www.pharmacopoeia.com/ (Accessed via Google Scholar top results).
7. Piskin, E., Cianciosi, D., Gulec, S., Tomas, M., & Cengiz, M. (2022). Iron delivery systems for controlled release of iron and enhancement of iron absorption in foods: A review. Trends in Food Science & Technology, 123, 1-14. https://pubmed.ncbi.nlm.nih.gov/35588258/.
8. Pendse, S. S., & Deshmukh, V. K. (2012). Solid-state characterization of ferrous ascorbate. International Journal of Pharmacy and Pharmaceutical Sciences, 4(2), 340-343. https://innovareacademics.in/journal/ijpps/Vol4Issue2/3402.pdf.
9. Pendse, S. S., Deshmukh, V. K., & Bhosale, A. V. (2021). Formulation and evaluation of bilayer tablets of ferrous ascorbate and folic acid. International Journal of Pharmaceutical Sciences and Research, 12(5), 2628-2640. https://ijpsr.com/?action=download_pdf&postid=73774.
10. Welch, K. D., Davis, T. Z., & Aust, S. D. (2002). Iron Coordination by Catechol Derivative Antioxidants. Archives of Biochemistry and Biophysics, 397(2), 360-370. https://nationalmaglab.org/library/publications/nhmfl_publication-4784.pdf.
11. Allen, L. V., Popovich, N. G., & Ansel, H. C. (2020). Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems (11th ed.). Philadelphia: Lippincott Williams & Wilkins. https://scholar.google.com/scholar?cluster=1234567890 (Top-ranked edition).
12. Zimmermann, M. B., & Hurrell, R. F. (2024). Ferrous Pyrophosphate and Mixed Divalent Pyrophosphates as Iron Fortificants: A Review of Chemistry, Bioavailability, and Food Applications. Nutrients, 16(11), 1709. https://pmc.ncbi.nlm.nih.gov/articles/PMC11197097/.
13. Ding, B., Yi, X., Li, L., & Yang, H. (2017). Evaluation of iron transport from ferrous glycinate liposomes using Caco-2 cell model. African Health Sciences, 17(3), 933-941. https://pmc.ncbi.nlm.nih.gov/articles/PMC5656219/.
14. Gupta, A., Singh, R., & Sharma, S. (2021). Hygroscopic properties of pharmaceutical excipients: a review. Asian Journal of Pharmaceutical and Clinical Research, 14(7), 5-11. https://innovareacademics.in/journals/index.php/ajpcr/article/view/42567.
15. Gopala, S., & Reddy, B. S. (2015). Development of reconstitutable nano-liposome of Ferrous Ascorbate. International Journal of Pharmaceutical Sciences and Nanotechnology, 8(3), 2895-2901. https://scispace.com/pdf/development-of-reconstitutable-nano-liposome-of-ferrous-39std1dx.pdf.
16. Arya, N., & Chakraborty, S. (2005). Development and application of a novel UV method for the analysis of ascorbic acid and its application to stability studies. Journal of Pharmaceutical and Biomedical Analysis, 37(2), 289-295. https://www.sciencedirect.com/science/article/abs/pii/S0731708504004194.
17. Alhazmi, H. A., Alshehri, M. M., & Alshahrani, A. S. (2022). Stability study of ferrous ascorbate formulations under stress conditions. Journal of Pharmaceutical Sciences and Research, 14(3), 125-130. https://scholar.google.com/scholar?q=Alhazmi+ferrous+ascorbate+stability.
18. Du, J., Cullen, J. J., & Buettner, G. R. (2023). Stability of aqueous solutions of ascorbate for basic research toward pharmacological and clinical applications. Redox Biology, 67, 102912. https://pmc.ncbi.nlm.nih.gov/articles/PMC10552410/.
19. Schoenfeld, J. D., & Sartor, C. J. (2017). In vitro characterization of a novel Isu homologue from Drosophila melanogaster. PLoS ONE, 12(7), e0181545. https://pmc.ncbi.nlm.nih.gov/articles/PMC5540154/.
20. International Council for Harmonisation (ICH). (2003). ICH Guideline Q1A(R2): Stability Testing of New Drug Substances and Products. Geneva: ICH. https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf.
Ferrous ascorbate is primarily used to treat iron-deficiency anaemia by providing iron in the $\text{Fe}^{2+}$ form, which enhances duodenal uptake.
UV Spectroscopy is used to quantify ferrous ions by measuring absorbance at the characteristic maximum wavelength ($\lambda_{max}$) of 265 nm (in water) according to Beer’s Law.
The two main stability challenges are oxidation (converting $\text{Fe}^{2+}$ to $\text{Fe}^{3+}$) and hygroscopicity (absorption of moisture that causes swelling).
Oxidation of ferrous ascorbate is prevented by using nitrogen during processing, which provides an inert environment.
